The role of dipeptidylpeptidase-4 inhibitors in management of cardiovascular disease in diabetes; focus on linagliptin

Multiple population based analyses have demonstrated a high incidence of cardiovascular disease (CVD) and cardiovascular (CV) mortality in subjects with T2DM that reduces life expectancy by as much as 15 years. Importantly, the CV system is particularly sensitive to the metabolic and immune derangem...

Descripción completa

Detalles Bibliográficos
Autores principales: Aroor, Annayya R., Manrique-Acevedo, Camila, DeMarco, Vincent G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5907287/
https://www.ncbi.nlm.nih.gov/pubmed/29669555
http://dx.doi.org/10.1186/s12933-018-0704-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5907287/
https://www.ncbi.nlm.nih.gov/pubmed/29669555
http://dx.doi.org/10.1186/s12933-018-0704-1

Ejemplares similares